company background image
BLT

BLIS Technologies NZSE:BLT Stock Report

Last Price

NZ$0.026

Market Cap

NZ$33.1m

7D

-3.7%

1Y

-46.9%

Updated

06 Dec, 2022

Data

Company Financials
BLT fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

BLT Stock Overview

BLIS Technologies Limited, together with its subsidiaries, develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity.

BLIS Technologies Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BLIS Technologies
Historical stock prices
Current Share PriceNZ$0.026
52 Week HighNZ$0.053
52 Week LowNZ$0.025
Beta0.55
1 Month Change-7.14%
3 Month Change-13.33%
1 Year Change-46.94%
3 Year Change-45.83%
5 Year Change52.94%
Change since IPO-97.37%

Recent News & Updates

BLIS Technologies (NZSE:BLT) Is In A Strong Position To Grow Its Business

Dec 05
BLIS Technologies (NZSE:BLT) Is In A Strong Position To Grow Its Business

Recent updates

BLIS Technologies (NZSE:BLT) Is In A Strong Position To Grow Its Business

Dec 05
BLIS Technologies (NZSE:BLT) Is In A Strong Position To Grow Its Business

Calculating The Intrinsic Value Of BLIS Technologies Limited (NZSE:BLT)

Mar 08
Calculating The Intrinsic Value Of BLIS Technologies Limited (NZSE:BLT)

BLIS Technologies Limited (NZSE:BLT) Insiders Have Been Selling

Feb 09
BLIS Technologies Limited (NZSE:BLT) Insiders Have Been Selling

BLIS Technologies Limited (NZSE:BLT) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Jan 21
BLIS Technologies Limited (NZSE:BLT) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

I Ran A Stock Scan For Earnings Growth And BLIS Technologies (NZSE:BLT) Passed With Ease

Jan 03
I Ran A Stock Scan For Earnings Growth And BLIS Technologies (NZSE:BLT) Passed With Ease

Should You Use BLIS Technologies's (NZSE:BLT) Statutory Earnings To Analyse It?

Dec 15
Should You Use BLIS Technologies's (NZSE:BLT) Statutory Earnings To Analyse It?

Introducing BLIS Technologies (NZSE:BLT), The Stock That Soared 371% In The Last Three Years

Nov 28
Introducing BLIS Technologies (NZSE:BLT), The Stock That Soared 371% In The Last Three Years

Shareholder Returns

BLTNZ PharmaceuticalsNZ Market
7D-3.7%1.1%2.1%
1Y-46.9%-23.8%-11.9%

Return vs Industry: BLT underperformed the NZ Pharmaceuticals industry which returned -23.8% over the past year.

Return vs Market: BLT underperformed the NZ Market which returned -11.9% over the past year.

Price Volatility

Is BLT's price volatile compared to industry and market?
BLT volatility
BLT Average Weekly Movement6.9%
Pharmaceuticals Industry Average Movement9.6%
Market Average Movement4.2%
10% most volatile stocks in NZ Market6.7%
10% least volatile stocks in NZ Market2.9%

Stable Share Price: BLT is more volatile than 90% of NZ stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: BLT's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of NZ stocks.

About the Company

FoundedEmployeesCEOWebsite
200047Brian Watsonhttps://www.blis.co.nz

BLIS Technologies Limited, together with its subsidiaries, develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity. The company markets two strains of probiotic bacteria, which include BLIS K12, a probiotic supplement to support ear, nose, and throat health of infants and children, as well as for improving bad breath; and BLIS M18 for promoting the bacterial balance for dental health. Its product portfolio consists of DailyDefence, a daily probiotic to support throat immunity; DailyDefence Junior, a daily powder formulation to support ear, nose, and throat health of infants and small children; ThroatGuard PRO to give immunity support to help protect against winter ills; ElitePRO, a suite of WADA tested products for athletes; and TravelProtect to help support the immune system when travelling.

BLIS Technologies Limited Fundamentals Summary

How do BLIS Technologies's earnings and revenue compare to its market cap?
BLT fundamental statistics
Market CapNZ$33.12m
Earnings (TTM)-NZ$2.60m
Revenue (TTM)NZ$9.47m

3.5x

P/S Ratio

-12.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BLT income statement (TTM)
RevenueNZ$9.47m
Cost of RevenueNZ$2.09m
Gross ProfitNZ$7.38m
Other ExpensesNZ$9.98m
Earnings-NZ$2.60m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.002
Gross Margin77.91%
Net Profit Margin-27.43%
Debt/Equity Ratio0.09%

How did BLT perform over the long term?

See historical performance and comparison